Skip to main content
OpenTrials

Clinical trial condition

Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Explore clinical trials studying Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive. Study availability and eligibility vary by location and protocol.

8 public trials 3 recruiting studies

Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive trial results

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States